Isoniazid, also known as isonicotinylhydrazide (INH), is an antibiotic often used for the treatment of latent and active tuberculosis. It can be used in combination with other medicines active against tubercolosis - rifampicin, pyrazinamide, and either streptomycin or ethambutol.
EML status history
First added in 1977 (TRS 615) for Tuberculosis
Application rejected in 2021 (TRS 1035) for Other specified tuberculosis
- Oral > Liquid: 50 mg per 5 mL
- Oral > Solid: 100 mg tablet; 100 mg tablet (dispersible); 300 mg tablet
- Parenteral > General injections > IV: 100 mg per mL